Back to Authors

Nguyen, Thuy

https://orcid.org/0000-0003-3545-3053

Mayo Clinic

Mayo Clinic

Citations 3

Brain multiomic profiling identifies tau-related transcriptomic dysregulation in Alzheimer’s disease
Oatman, Stephanie R., Quicksall, Zachary , Wang, Xue, Bergman, Jeremiah, Reddy, Joseph S, Vanelderen, Floor , Nguyen, Thuy , Malphrus, Kimberly, Lincoln, Sarah, Martens, Yuka A. , Zhao, Na, Yamazaki, Yu, DeTure, Michael, Bu, Guojun, Kanekiyo, Takahisa , Allen, Mariet , Ertekin‐Taner, Nilüfer , Lincoln, Sarah J, Murray, Melissa E , Kanekiyo, Takahisa , Dickson, Dennis W , Ertekin-Taner, Nilüfer , Reddy, Joseph S. , Malphrus, Kimberly G., Yamazaki, Yu , DeTure, Michael , Murray, Melissa E. , Liu, Chia‐Chen , Bu, Guojun , Dickson, Dennis W.

Brain Communications | August 27, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1093/braincomms/fcag326 Get It

Abstract Identification of gene expression changes in post-mortem brain tissue of Alzheimer’s disease donors compared to controls have implicated numerous biological pathways for Alzheimer’s disease pathophysiology. Nonetheless, there is still limited understanding of how gene expression dysregulation underpins specific proteinopathies core to Alzheimer’s disease. Here we investigate brain transcriptomic changes in a well characterized cohort of Alzheimer’s disease donors to identify genes and networks that associate with Alzheimer’s disease endophenotypes including neuropathology measures (Braak stage, Thal phase and cerebral amyloid angiopathy score) and Alzheimer’s disease-related brain protein levels (Apolipoprotein E, Amyloid-β 40, Amyloid-β 42, tau, and phospho-Tau). Bulk transcriptome measures were collected from the temporal cortex tissue of 477 Alzheimer’s disease donors. Following quality control, transcriptome-wide association studies were performed for each endophenotype. We used weighted gene co-expression network analysis to build co-expression networks and integrated transcriptome with epigenetic and genetic data from the same donors. We detected a total of 5,740 Bonferroni significant temporal cortex gene associations with Alzheimer’s disease endophenotypes, most of which were with brain tau levels. We discovered tau-associated co-expression modules enriched in known and novel Alzheimer’s disease pathways. We found that a beneficial (or neutral) brain biochemical state of higher total tau and lower phospho-Tau are associated with increased levels of synaptic, DNA damage/repair, nucleic acid metabolism and myelin processes. In contrast, in a detrimental state of lower total and higher phospho-Tau, there is upregulation of vascular and immune, and downregulation of mitochondrial and myelin pathways. There are brain gene expression perturbations that are associated with Alzheimer’s disease endophenotypes. While some of these associations are common across multiple endophenotypes, many are distinct for different Alzheimer’s disease-related proteins. Based on these findings, we propose a hypothetical model of dynamic brain gene expression changes that track with progressive Alzheimer’s disease proteostasis. These expression changes hold potential to serve as dynamic, precision biomarkers of brain Alzheimer’s disease progression. This study demonstrates the potential of integrative multiomics and deep Alzheimer’s disease endophenotype analyses in well-characterized brain tissues to uncover with precision the complex biology of Alzheimer’s disease.
Peripheral cellular transcriptional changes are associated with Alzheimer’s disease related phenotypes 2330291
Wang, Xue, Tsai, Wei, Nguyen, Thuy , Reyes, Denise, Lowe, Val, Petersen, Ronald, Kantarci, Kejal, Carrasquillo, Minerva, Nho, Kwangsik, Saykin, Andrew, Reddy, Joseph, Allen, Mariet , Ertekin-Taner, Nilüfer, Chen, Xuan , Tsai, Wei, Lowe, Val J. , Petersen, Ronald C. , Kantarci, Kejal , Carrasquillo, Minerva M. , Nho, Kwangsik T. , Saykin, Andrew J. , Reddy, Joseph S. , Ertekin‐Taner, Nilüfer

The Journal of Immunology | July 28, 2026 | Volume: 215 | Issue: Supplement_1 | Pages: No page available

10.1093/jimmun/vkag141.1795 Get It

Abstract Introduction Alzheimer’s disease (AD) is characterized by pathologies including amyloid, tau, neurodegeneration reflected in established blood biomarkers and track with clinical changes. However, the association between peripheral cell-specific signatures and AD-related phenotypes remain poorly characterized. Methods We analyzed bulk blood transcriptome data from the Mayo Clinic Study of Aging (MCSA) and Emory University Vascular study. We used BayesPrism, CIBERSORTx, and an in-house pipeline CNNreg to deconvolute these data and obtain peripheral cell proportions. Cell type specific transcripts were estimated with BayesPrism. We compared cell proportions between cases (AD/MCI) and controls. Association analysis was performed between cell type specific transcripts and AD-related phenotypes including diagnosis and cognition. Meta-analysis of transcripts associations and gene ontology analysis were conducted to assess the enriched pathways for significant genes. Results In MCSA, B and CD4+ T cells proportions are significantly lower while that of myeloid cells higher in cases. The Emory cohort had similar trends. We identified transcripts associated with AD-related phenotypes in CD4+ T and CD8+ T cells. In CD4+ T cells, transcripts downregulated in case are enriched in response to stimulus pathway, whereas those upregulated in negative regulation of immune response. Downregulation of CD4+ T genes enriched in extracellular matrix disassembly and epigenetic regulation and upregulation of those in protein localization associate with better cognition. In CD8+T cells, genes pertinent to vascular development were downregulated while those to metabolic processes were upregulated in cases. Downregulation of CD8+T genes involved in lipid transportation and upregulation of those in mitochondria associate with better cognition. Conclusion We identified peripheral cellular transcriptional changes associated with AD/MCI phenotypes and involved in important biological pathways, revealing potential disease mechanisms in AD. Funding Source RF1 AG051504 Topic Categories Neuroimmunology (NEUR)